Griffithsin Purification Process for Low-Cost Large-Scale Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bioprocesses for producing Griffithsin are unable to achieve large-scale production volumes (e.g., >20 tons per year) at affordable costs (below $10,000/kg) due to high downstream recovery and purification costs, primarily from inefficient removal of host cell proteins and nucleic acids.
Innovation Solution
A bioprocess involving recombinant expression of Griffithsin in engineered E. coli using a low phosphate inducible promoter, followed by a single precipitation step at specific temperature and pH conditions to remove contaminants, and a single chromatography step to remove residual endotoxin, resulting in high purity and activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional production methods are used for antiviral proteins, then production costs are high, but production volume and purity are insufficient for widespread SARS-CoV-2 prevention and treatment
Solution Approach 1:
The patent applies parameter changes by optimizing precipitation conditions (temperature, pH, ammonium sulfate concentration) to achieve high-volume production with improved purity and reduced costs. Specifically, precipitating at temperatures above 55°C with ammonium sulfate concentrations greater than 0.8 M and pH less than 4 enables removal of over 99% of host cell proteins while maintaining production scalability
Solution Approach 2:
The patent extracts and removes contaminating substances through the precipitation step that eliminates host cell proteins and nucleic acids, followed by anion exchange chromatography to remove residual endotoxin. This extraction approach achieves virtually complete removal of contaminants while maintaining high production volumes
2Manufacturing precision
If multiple purification steps are used to achieve high purity, then production cost increases, but production efficiency decreases
Solution Approach 1:
The patent merges multiple purification functions into a single precipitation step that simultaneously removes host cell proteins, nucleic acids, and other contaminants. This combined approach achieves over 99% removal efficiency for multiple contaminant types in one operation, followed by a single chromatography step for endotoxin removal, thereby maintaining high purity while improving production efficiency
Solution Approach 2:
The patent uses parameter changes in the precipitation step (temperature above 55°C, ammonium sulfate concentration greater than 0.8 M, pH less than 4) to optimize the simultaneous removal of multiple contaminants, achieving high purity in a single step rather than requiring multiple sequential purification operations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves production volumes of over 20 tons per year at costs below $10,000/kg, ensuring >99% purity and activity, making it suitable for large-scale antiviral applications like SARS-CoV-2 prevention and treatment.
Implementation Method 1
performing a precipitation step to remove contaminating protein and nucleic acids performed at temperatures greater than 55° C., (NH4)2SO4 concentrations greater than 0.8 M and a pH less than 4
Implementation Method 2
performing at least one anion exchange chromatography purification step
Implementation Method 3
performing a precipitation step to remove contaminating protein and nucleic acids performed at temperatures greater than 55° C.
Data Source
AI summary
Methods and kits are provided for producing Griffithsin. The methods include providing a genetically modified microorganism comprising a gene encoding Griffithsin protein operably linked to an inducible promotor and growing the genetically modified microorganism under conditions that induce the promotor and cause expression of griffithisin. The Griffithsin is purified by releasing Griffithsin from the microorganism by cellular disruption, performing a precipitation step to remove contaminating protein and nucleic acids, and performing an anion exchange chromatography step.